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Summary.-Using competitive double-antibody radioimmunoassays we have shown
that immunoglobulin (especially IgA) can be recovered in pH 3-5, 012M acid citrate
eluates of freshly excised CCHl tumour-cell suspensions. Studies with 1251-labelled
eluates indicate that such preparations exhibit a variable, but appreciable, degree of
non-specific binding to unrelated syngeneic tumour and normal tissues. PAGE/SDS
gel electrophoresis of the labelled eluates revealed the presence of a major non-
immunoglobulin component of 33-36K dalton which could account in part for the
non-specific binding observed. This component was also detected in similar eluates
from cultured CCH1 tumour and in all other tumour-cell eluates examined to date.
In contrast, preliminary data suggest that it is less prevalent in acid citrate eluates
from normal tissue, with the exception of peritoneal-exudate cells. The possible
origins, nature and significanceofthisnon-immunoglobulincomponentarediscussed.
PREVIOUS STUDIES from our laboratory
have shown that appreciable amounts of
host immunoglobulin may be associated
with certain solid tumours in vivo (James
et al., 1978a, 1979). In view of these
observations it seemed important to
establish whether we could recover any
immunoglobulin from the surface of these
tumour cells, with the aim of establishing
its specificity.
We decided to approach this problem
by using the acid citrate elution procedure
previously used by Maov & Witz (1978) to
elute immunoglobulin from the surface of
tumour cells grown in ascitic form. As a
result ofthis approach (see below) we have
found that appreciable amounts of im-
munoglobulin can be recovered from
freshly excised tumour-cell suspensions,
but these eluates may exhibit a consider-
able amount of non-specific binding. In
addition they also contain large amounts
of a non-immunoglobulin component of
approximately 33-36K dalton which is
also present in eluates from cultured
tumour cells. The results of preliminary
experiments undertaken to establish the
origins and nature of this component and
its possible uniqueness to the malignant
phenotype are also described.
MATERIALS AND METHODS
Animals.-Unless otherwise stated, the in
vivo procedures were performed in inbred
CBA/Ca male mice aged 10-12 weeks. These
mice were bred from stock originally obtained
from the MRC Laboratory Animals Centre,
Carshalton, Surrey.
Tumoars.-Most of the results reported in
the present paper were obtained with a
methylcholanthrene (MC) induced tumour
(CCHI) of CBA origin (Woodruff et al., 1972).
Other tumours examined included: a fibro-
sarcoma (T3) which arose by spontaneous
transformation of CBA embryo cells in vitro
(Smith & Scott, 1972); an MC-induced fibro-
sarcoma (FSa) and a spontaneous mammary
carcinoma (MCa2) from C3H/HeJ mice (both
supplied by Dr W. H. McBride, Department
of Bacteriology, University of Edinburgh); a
spontaneous T-cell leukaemia (Th) and neckPROPERTIES OF TUMOUR-CELL ELUATES
carcinoma (NT) ofCBA/Ht mice (kindly sup-
plied by Dr H. B. Hewitt, King's College
Hospital Medical School, London); 2 MC-
induced tumours (Mc7, MC40A) of rat origin
(provided by Dr N. Willmott, Department
of Medical Oncology, University of Glasgow)
and finally a macrophage-like mouse tumour
line (the P388D1, originally described by
Koren et al., 1975).
In certain cases the tumours were main-
tained by in vivo passage (e.g. CCH1, T3, Th,
NT, FSa and MCa2). In others they had been
adapted to culture in RPMI medium con-
taining 10%/ (v/v) foetal calf serum (CCH1,
Mc7, Mc4OA) or Ham's medium containing
foetal calfserum (P338D1).
Single-cell suspensions were usually ob-
tained from solid freshly excised non-
necrotic tumour tissue by digestion oftumour
fragments with a mixture of trypsin (0.1 mg/
ml; Difco), collagenase (0.1 mg/ml Grade A;
Calbiochem Behring) and deoxyribonuclease
(0.04 mg/ml; Sigma). However, on occasions
(see below) the trypsin concentration was
increased to 1 mg/ml, or pronase (0.25-2.5
mg/ml) was used in place of trypsin and
collagenase. The Th leukaemia cells were
obtained by peritoneal lavage with Dulbecco
A solution. Cultured tumour cells were
normally harvested by displacement from the
culture flasks with a fine jet of medium con-
taining 0-02% (w/v) EDTA.
Suspensions of normal CBA mouse tissues
(namely thymus, lymph nodes, spleen,kidney,
lung and liver) were prepared by either the
standard enzyme digestion described above
or by mechanical disruption in a ground-
glass homogenizer. Peritoneal exudate cells
were harvested by peritoneal lavage of non-
stimulated mice with heparinized (10 u/ml)
complete RPMI.
The viability of all preparations was
routinely assessed by trypan-blue dye ex-
clusion and usually exceeded 90%.
Preparation ofeluates.-Tumour-cell eluates
were generally obtained by the procedure of
Maov and Witz (1978) which involved in-
cubating tumour cells for 15-20 min at room
temperature in pH 3.5, 0 12M acid citrate
buffer (2 x 107 cells/ml). Control eluates were
prepared in 0-06M phosphate-buffered saline
(pH 7.2) containing 0-15M NaCl or Dulbecco
PBS. On occasions alternative elution con-
ditions were used (see below). When necessary
the eluates were concentrated by ultrafiltra-
tion through 8/32 visking tubing or Amicon
B15 concentrators (Amicon, Lexington,
Massachusetts, U.S.A.) and stabilized by the
addition of 10 1ul/ml kallikrein inactivator
(Calbiochem/Behring).
Protein determinations.-The total protein
content of samples was determined by the
Folin Phenol procedure, while the concentra-
tion of individual immunoglobulin isotypes
was assessed by a competitive double anti-
body radioimmunoassay (James et al., 1979).
Labelling procedures.-The tumour-cell
eluates were labelled with 1251 by the
chloramine T procedure of Hunter & Green-
wood (1962), free iodine being removed by
dialysis or G25 Sephadex-gel filtration.
Membrane proteins were labelled in
situ with 1251 by the glucose-oxidase lacto-
peroxidase technique of Hubbard & Cohn
(1972). After iodination the cells were either
extracted with 0.5% (v/v) NP40 or eluted
with acid citrate or phosphate-buffered
saline as above.
In order to determine the effect of acid
citrate elution on membrane permeability,
the tumour cells (108) were occasionally
labelled with 51chromium (35 DCi) using the
technique described by Bainbridge & Gow-
land (1966) for lymphocytes.
Enzymological assays.-Permeability effects
were also ascertained by determining the
levels of various enzymes in acid citrate and
phosphate-buffered saline eluates. Lactic
dehydrogenase (a cytoplasmic marker) was
determined by the method of Wroblewski &
Ladue (1955) while n-acetyl-/-glucosamin-
idase (a lysosomal enzyme) was measured by
the technique of Woollen et al. (1961).
Polyacrylamide-gel electrophoresis-.Poly-
acrylamide-gel electrophoresis in sodium
dodecyl sulphate (PAGE/SDS) was per-
formed essentially according to the method
of Laemmli (1970). Before electrophoresis the
samples were diluted with an equal volume
of sample buffer (which usually contained
0-06M /3-mercaptoethanol) and boiled for 5
min. Aliquots of the boiled and reduced pro-
tein (100 ,ul containing 1-2 /g protein) were
then applied to the slab gels. The polyacryl-
amide concentration of the stacking gels was
5% (v/v) while that of the running gel was
10%. A standard cocktail was included on all
gels, the subunit mol. wt of the components
ranging between 14,100 and 94,000 daltons.
This mixture was purchased from Pharmacia
U.K. Ltd. On occasions an internal standard
was also included, namely 131I1-labelled
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mouse IgG. After electrophoresis at 25mA/
plate for 5 h the gels were fixed in methanol-
acetic acid-water (25, 10, 65% respectively),
stained in0 25% Coomassie Blue inmethanol-
acetic acid-water (45, 9, 46% respectively)
and destained in methanol-acetic acid-water
(10, 10, 80% respectively). The gels were then
usually sliced into 3mm segments and counted
in the LKB gamma scintillometer.
The results are presented as either counts
per fraction or the percentage of total counts
recovered in any one fraction. The latter
values were obtained by analyses on an ICL
2900 series computer and were plotted with a
Calcomp graph plotter. The programme
devised computed mol. wt positions in addi-
tion to calculating the percentage of total
counts in each fraction. This computation
was achieved by linear regression analysis on
the distance migrated by the marker proteins
and the log of their mol. wt.
Binding assays.-The binding properties of
some of the eluates was assessed as follows.
Test samples labelled with 1251 were diluted
to 0-2 to 10 ,ug/ml in PBS containing 10 mg/
ml BSA. One-ml samples of the various
dilutions were then added to 104-107 pelleted
target cells. These mixtures were then incu-
bated for 1 h at room temperature with inter-
mittent shaking. The samples were then
washed ( x 4) with Hanks' solution and trans-
ferred to fresh tubes for counting. Control
tubes without target cells were processed in
parallel.
Fc-receptor studie8.-In the light of recent
suggestions that the 33K component may be
an Fc-receptor-like molecule (Ran & co-
workers, unpublished) we have examined the
interaction of 125J-labelled eluates with
aggregated mouse IgG and aggregated
albumin. The mouse IgG was prepared by
sodium phosphate precipitation followed by
DEAE cellulose column chromatography.
This preparation was centrifuged for 1 h at
2000 g and subsequently aggregated by heat
denaturation at 63°C for 20 min.
Labelled eluates (100 ,ul containing 5 ,ug
protein) were incubated for 30 min at 37°C
with 10 mg of aggregate "deficient" or aggre-
gate rich protein. The samples were then
applied to a calibrated G200 sephadex
column (60 x 2-5 cm). The distribution of
protein and radioactivity in the effluent
was monitored by UV spectroscopy and
gamma counting respectively. Effluent
fractions were pooled as indicated in Fig. 7,
concentrated and subjected to PAGE/SDS
gel analyses.
RESULTS
Immunoglobulin content of tumour eluates
and extracts
The competitive double-antibody radio-
immunoassay studies confirmed our pre-
vious observations that small amounts of
immunoglobulin (especially IgA) were
TABLE I.-The immunoglobulin content of extracts and eluates of a transplanted methyl-
cholanthrene inducedfibrosarcoma (CCH1)
Prep.
No. Source
Freshly
excised
2 Freshly
excised
3 Freshly
excised
4 Freshly
excised
5 Cultured
No. of
cells
treated
107
Mode of
treatment
NP40
Dulbecco PBS
Acid citrate
107 NP40
Dulbecco PBS
Acid citrate
107 Dulbecco PBS
Acid citrate
9 X 107 Dulbecco PBS
Acid citrate
107 NP40
Dulbecco PBS
Acid citrate
Immunoglobulin (ng/ml),+~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
M
<1
< 1
< 1
A
17
<6
7
1-6 18
<1 <6
1-6 7
0
4-2
3-7
5-7
1-9
56-0
6-6
100
<1 <6
<1 <6
1-6 <6
GI
2-7
2-7
1-6
3-4
2-4
2-5
3-7
3-2
3-7
3-7
<1*6
<1-6
<1-6
G2a G2b
4-9 5.7
5-8 5-1
4-7 5.0
4-2 5.5
3-4 4-5
3-3 4-4
NT NT
NT NT
NT NT
NT NT
3 <0-5
3 <0 5
3 <0.5
Appreciable amounts of a number of Ig isotypes are recovered in both Dulbecco PBS and acid citrate eluates from freshly excised tumours, but the latter preparations appear to be particularly rich in IgA.
The apparent absence of Ig in eluates and extracts of cultured tumour cells has been noted previously.
NT = Not tested.-
G3
NT
NT
NT
NT
NT
NT
<3
10.1
<3
12-5
NT
NT
NT
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Exp.
No.
Eluate
added
Acid citrate
2a Acid citrate
2b Acid citrate
3a Acid citrate
3b Dulbecco PBS
of 125I-labelled eluates from a freshly excised fibrosarcoma
(CCH1) to various syngeneic targets
Amount
added
(/Kg)
1
10
0-1
1
10
0-1
10 10
10
10
No. of
cells/
test
3 x 106
3 x 106
106
106
106
107
107
107
8 x 106
8 x 106
ng bound to
CCHI
17-6
189
1-1
4-1
220
2-8
18
470
81.1
89-2
T3
14-0
163
NT
NT
NT
NT
NT
NT
NT
NT
Spleen
95
0-6
2
8
0 9
3-6
17
Thymus
8-2
53
0-7
2-3
20
0*9
2-6
13
4-1 2-2
6 3-4
NT =Not tested.
Note.-While proteins eluted from freshly excised tumour bind readily to cultured autologous targets,
components in the eluate also bind to other syngeneic targets. This non-specificity varies from preparation
to preparation. In addition Dulbecco PBS eluates exhibit similar properties.
present in NP40 extracts of CCH1
tumours. Furthermore, it would appear
that appreciable amounts of certain ofthe
immunoglobulins could be recovered by
eluting the cells in Dulbecco-PBS or acid
citrate buffer (Table I). Of particular
interest, however, was the observation
that more IgA and G3 was recovered in
acid citrate eluates than in those prepared
using Dulbecco PBS. Finally, as antici-
pated, the amounts of immunoglobulin
recovered from cultured cells was negli-
gible.
Interaction ofacid citrate eluate with normal
and malignant tissue
These studies demonstrated that
labelled acid citrate eluate proteins ex-
hibited a significant (though variable)
amount of non-specific binding (Table II).
In addition to interacting with cultured
autologous tumours they also bound to an
unrelated tumour and normal tissue of
syngeneic origin. This lack of specificity
was particularly apparent with the pre-
paration used in Exp. 1. Of additional
interest was the observation that proteins
eluted with Dulbecco PBS exhibited
similar reactivity. Asindicated above, such
preparations normally contained com-
paratively small amounts of IgA and
IgG3.
It should also be stressed that, whilst
some ofthe labelled protein in acid eluates
bound to thymus, we were unable at any
time to detect antibodies capable of
effecting complement-mediated lysis of
these targets.
No attempts were made at this stage to
improve the specificity of the eluted anti-
body by absorption with unrelated tumour
or normal tissue. We decided instead to
direct our attention to characterizing
these eluates by the PAGE/SDS tech-
nique (see below).
PAGE/SDS characteristics ofacid eluates
Contrary to expectations, our initial
studies revealed that the major high-mol.-
wt component (i.e. > 20K) in eluates was
not immunoglobulin but a polypeptide of
between 33 and 36K dalton (Fig. 1).
Further support for the non-immuno-
globulin nature of this component was
obtained by performing gels on mixtures
of 131I-labelled mouse immunoglobulin
and 1251-labelled eluate (Fig. 2). In
addition, it was also found in acid citrate
eluates of cultured cells (Fig. 1), which
contain little, if any, immunoglobulin.
Parallel PAGE/SDS analyses of the
chloramine T-labelled eluates and NP40
extracts of cells labelled by lacto-
peroxidase-catalysed iodination clearly
TABLE II.-The binding
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FIG. 1.-PAGE/SDS analysis of acid citrate
eluates from freshly excised and cultured
CCHl tumour cells. The freshly excised (A)
and cultured (B) eluates were labelled with
125I by the chloramine T procedure and
run on 10% PAGE/SDS gels under both
reducing and non-reducing conditions.
Note that excluding the low-mol.-wt peak
which moves with the bromophenol blue
front the major component in both prepara-
tions is a molecule of33-36 K dalton which
exists as a single polypeptide chain.
demonstrated that the labelled eluate was
not representative of the cell surface
proteins (Fig. 3).
The presence of this distinct protein in
labelled acid citrate eluates from tumour
cells prompted us to investigate its pre-
sence in a variety ofnormal and malignant
tissues. This protein has been detected in
the acid citrate eluates of all the tumours
referred to in the Materials and Methods
section. Thus its presence appears to be
independent of the origins of the tumour
(chemically induced or spontaneous), the
mode of maintenance (in vivo or in vitro)
or species of origin (mouse or rat). In
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FIG. 2. PAGE/SDS analysis of acid citrate
preparations containing an internal mark-
er. In this experiment a trace amount of
1311-]abelled mouse IgG was added to
125I-labelled eluates prior to PAGE/SDS
analysis under reducing conditions. Note
that the major polypeptide chain detected
in eluates has a mol. wt. intermediate be-
tween heavy and light chains ofIgG.
addition, it is found in eluates from both
carcinomas and sarcomas. The results
obtained with some of the tumours are
presented in Figs 4-6.
By way of contrast, our studies to date
suggest that this protein is less prevalent
in similar preparations from normal tissue
with the possible exception of peritoneal-
exudate cells (Fig. 4-6). Nevertheless, it
should be stressed that certain of the
preparations from mechanically disrupted
normal tissue did contain appreciable
amounts of other proteins. For example, a
25K component has been found in eluates
from some mechanically prepared liver-cell
suspensions (Fig. 5). Furthermore, proteins
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Fia. 3. A comparison of the PAGE/SDS
patterns of cell-surface labelled and acid
citrate eluate proteins. In these studies
membrane proteins were labelled in situ
with 125I by glucose oxidase-lactoperoxi-
dase catalysed iodination (above), whilst
acid citrate eluates were labelled with the
same radionuclide by the chloramine T
procedure&(below). Note that NP40 extracts
of cell-surface labelled proteins exhibit
greater heterogeneity than labelled acid
citrate eluates, which appear relatively
devoid of proteins with polypeptide chains
> 40 K dalton.
of 30K and 20K have on occasion been
seen in eluates of mechanically disrupted
thymus and kidney respectively (data not
included).
Factors influencing the release of the 33K
component
A number of experiments have been
performed to establish whether the release
of the 33K component is dependent upon
the elution conditions. Certain of these
studies (data omitted) indicated that the
release of the protein under acid con-
ditions is a rapid event. Elution is evident
after 1-min incubation at either 4°C or
room temperature. Furthermore, the pro-
tein was present in eluates from cells
which had been treated with high concen-
trations of trypsin and pronase (1 mg and
2-5 mg/ml respectively), observations
which indicate that this protein is not
readilystrippedfrom the surface oftumour
cells. However, in contrast to the above,
the protein is not effectively eluted with
PBS, nor have we been able to identify it
in acid citrate eluates from tumours
which have been pre-labelled by the
lactoperoxidase technique. Finally, it
should be noted that in the absence of
proteolytic inhibitors the protein under-
goes gradual degradation on storage.
Fc-receptor studies
During the course of these investiga-
tions we learned that a protein of similar
size had been noted by others in acid
citrate eluates of tumours (Ran et al.,
unpublished). On the basis of a number
of observations these investigators con-
cluded that their protein was an Fc-
receptor-like molecule. This suggestion
proved intriguing for a variety of reasons,
but especially as previous studies from our
own laboratory had shown that the CCH1
tumour used did not express Fc receptors
(Szymaniec & James, 1976). Nevertheless,
there was the possibility that the Fc re-
ceptors were present but only became
exposed by acid citrate treatment.
Our gel-filtration studies revealed that
there was indeed a component in eluates
from both freshly excised and cultured
tumours that exhibited one of the prin-
cipal characteristics of the Fc receptor,
namely interaction with aggregated IgG
(see Fig. 7). This interaction was also con-
firmed by PAGE/SDS analysis of con-
centrated effluent fractions. However, it
was also apparent from both the gel
filtration and PAGE/SDS studies that an
appreciable proportion of the 33-36K
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FIG. 4.-A comparison of the PAGE/SDS patterns of labelled acid citrate eluates from normal and
malignant tissues. Note the presence of a dominant 33-36 K component in eluates obtained from
mouse (CCH1 and FSA) and rat fibrosarcomas (MC40a) but not in spleen. Observe also the addi-
tional 55 K component in the FSA eluate.
fraction remained unbound. Additional
studies indicated that there was a com-
ponent in the eluate which also bound
equally well to aggregated albumin (data
not included). This suggests that the inter-
action noted was perhaps a non-specific
hydrophobic one rather than a genuine
Fc-receptor-aggregated IgG interaction.
Origins of the 33K component
Having firmly established the presence
of a readily labelled 33-36K component
in tumour-cell eluates a number of ex-
periments were performed to ascertain
whether the protein was a genuine cell
product, or was passively acquired in
vitro or in vivo. The results ofthese experi-
ments were as follows.
PAGE/SDS analysis performed on im-
munoprecipitates from 3 different eluate
preparations revealed that this component
was not a passively acquired mouse or
bovine plasma protein. There was some
indication however that it exhibited the
propensity to interact with antigen-anti-
body precipitates, especially those in-
volving albumins. This propensity was
also revealed by immuno-diffusion and
immunoelectrophoresis.
Preliminary biosynthetic studies (data
not included) also suggested that the pro-
tein may be synthesized by tumour cells,
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Fic. 5.-A comparison of the PAGE/SD)S patterns of labelled acid citrate eluates from normal an(l
malignant tissues. Note the presence of a major 33-36 K component in eluates from a rat fibro-
-sarcoma (Mc7) and normal mouse peritoneal exudate cells. The liver preparation did, however,
contain a major component of 25 K dalton.
though further studies will be necessary
to unequivocally establish this point.
Additional experiments were also per-
formed to ascertain whether the 33-36K
protein might be an intracellular com-
ponent released during the acid elution.
While enzymological and other analyses
(see Table III) indicated no gross leakage
of intracellular material the possibility
still remains that this protein is of cyto-
plasmic origin, and not an integral mem-
brane component.
DISCUSSION
The present experiments clearly demon-
strate that immunoglobulin (especially
IgA) can be recovered from a freshly
TABLE III. The acid citrate-mediated re-
lease of various
tumour cells
Marker assaye(l
Lactic dehydrogenase
N-acetyl :-D
glucosaminidiase
5IChiromiumt
Biosynthetically
labellecd proteinstj
"markers" fromt CCH1
% Total activity
released by
Acidl
citrate PBS
0-1 (3)* 21 (3)
10 (4)
13-9, 6-6
1-3, 1-3, 1-8,
4-1, 5 '3
8 (5)
6, 3-7
NT
* The values in brackets weie obtaiined in parallel
studlies on spleen cells.
t Tile results of separate experiments are given.
I This is an estimate of the amount of 35S-
methionine, 75Se-methionine or 3H-leucine labelled
protein released by aci(d citrate treatment.
Note. Gross leakage of intracellular components
(toes not occur. NT=not teste(d.
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Fie. 6. A comparison of the P'AGE/SDS patterns of labelled acid citrate eluates from normal anld
malignant tissues. Note the presence of appreciable amounts of the 3:3-36 K component in eluates
fr'om the mouse fibrosarcoma (FSA) andl the macrophage-derived tumour cell line (P338D1). In
contrast it appeairs less prex alent in eltiates from normal long an(l spleen.
excised methylcholanthrene-induced tum-
our, using the acid citrate elution pro-
cedure previously described by Maov &
Witz (1978). Unfortunately, the proteins
eluted exhibit a considerable degree of
non-specific binding. While lack of speci-
ficity is most probably due to the presence
of non-specific antibodies in the eluates,
the possibility that it is in part due to the
presence of a readily labelled hydrophobic
non-immunoglobulin component cannot
be ignored. Trhis particular 33-36K dalton
component appears to be present in
relatively high concentrations in pre-
parations from a variety of cultured
and freshly excised tumours. In contrast,
it is less prevalent in eluates from nor-
mal cells. However, further comparative
studies on a variety of normal and malig-
nant tissues will be necessary to firmly
establish whether this protein is more pre-
dominant on malignant cells.
A protein similar to the above has also
been observed by Ran and her co-workers
(unpublished) in acid citrate eluates of a
variety of murine and human tumours.
They have suggested that the protein may
by an Fe-receptor component. While our
present observations indicate that the
33-36K fraction molecule exhibits some of
the properties of Fc receptors, namely in-
teraction with aggregated IgG and certain
antigen/antibody precipitates, other ob-
servations lead us to conclude that it may
not be a "classical" Fc receptor, for it also
interacts with aggregated albumin. Un-
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Fia. 7.-G200 sephadex gel-filtration analysis
of the interaction between the 1251-labelled
acid citrate eluate of freshly excised CCH1
tumour cells and normal or heat-aggregated
mouse IgG. Note that heat aggregation of
the mouse IgG increases the amount of
protein eluted in the void volume. This is
also accompanied by an increase in the
amount oflabelled eluate excluded from the
gel, suggesting that a component in this
preparation binds readily to aggregated
IgG.
doubtedly further studies will be necessary
to clarify this very important point.
Whilst our unpublished biosynthetic
studies and immunoprecipitation investi-
gations lead us to believe that the 33-36K
component is a genuine cell product and
not of exogenous origin, we have still not
yet established whether it is an integral
membrane component, a membrane-asso-
ciated protein (possibly of cytoplasmic
origin) or simply a released intracellular
protein. If it is a membrane protein
(integral or otherwise) several observa-
tions suggest that it is not readily access-
ible. In the first place it is not effectively
labelled by enzyme catalysed iodination.
Furthermore, it is not readily eluted with
PBS or stripped from the cell surface with
proteolytic enzymes. It should perhaps
22
also be stressed that previous virological
investigations undertaken on the CCH1
tumour lead us to believe that the protein
is not ofviral origin (James etal., 1978a, b).
At present, the significance of our
observations remains to be established.
Nevertheless, it is apparent that they
reveal a matter of considerable practical
importance to those studying or exploiting
the properties of antitumour antibodies
recovered from tumour cells by elution
with low-pH buffers. It should be appre-
ciated that unless such preparations are
further fractionated to yield the Ig-
containing fraction, the results obtained
with chloramine-T-labelled products can
be very misleading. As stressed above, the
unfractionated eluates contain appreciable
amounts ofareadily labellednon-immuno-
globulin protein with the propensity to
bind to aggregated IgG and antigen anti-
body complexes. It is also conceivable
that it might readily interact with hydro-
phobic regions on the surface ofthe target
cell.
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